nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—ABCC2—Sorafenib—thyroid cancer	0.214	0.383	CbGbCtD
Spironolactone—ABCC2—Doxorubicin—thyroid cancer	0.13	0.232	CbGbCtD
Spironolactone—CYP2C8—Sorafenib—thyroid cancer	0.103	0.184	CbGbCtD
Spironolactone—ABCB1—Sorafenib—thyroid cancer	0.0698	0.125	CbGbCtD
Spironolactone—ABCB1—Doxorubicin—thyroid cancer	0.0424	0.0757	CbGbCtD
Spironolactone—Gastrointestinal symptom NOS—Sorafenib—thyroid cancer	0.00753	0.0471	CcSEcCtD
Spironolactone—Lethargy—Vandetanib—thyroid cancer	0.00486	0.0304	CcSEcCtD
Spironolactone—Gastritis—Vandetanib—thyroid cancer	0.00422	0.0264	CcSEcCtD
Spironolactone—Gynaecomastia—Sorafenib—thyroid cancer	0.00396	0.0248	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Vandetanib—thyroid cancer	0.00364	0.0228	CcSEcCtD
Spironolactone—Renal failure—Vandetanib—thyroid cancer	0.00361	0.0226	CcSEcCtD
Spironolactone—Renal failure acute—Sorafenib—thyroid cancer	0.00348	0.0218	CcSEcCtD
Spironolactone—Erythema multiforme—Vandetanib—thyroid cancer	0.00312	0.0195	CcSEcCtD
Spironolactone—Alopecia—Vandetanib—thyroid cancer	0.00291	0.0182	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Sorafenib—thyroid cancer	0.00289	0.0181	CcSEcCtD
Spironolactone—Gastritis—Sorafenib—thyroid cancer	0.00284	0.0178	CcSEcCtD
Spironolactone—Muscle spasms—Vandetanib—thyroid cancer	0.00276	0.0173	CcSEcCtD
Spironolactone—SHBG—neck—thyroid cancer	0.0026	0.105	CbGeAlD
Spironolactone—Erectile dysfunction—Sorafenib—thyroid cancer	0.00256	0.016	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Sorafenib—thyroid cancer	0.00246	0.0154	CcSEcCtD
Spironolactone—Renal failure—Sorafenib—thyroid cancer	0.00244	0.0152	CcSEcCtD
Spironolactone—Thrombocytopenia—Vandetanib—thyroid cancer	0.00229	0.0143	CcSEcCtD
Spironolactone—Rash erythematous—Epirubicin—thyroid cancer	0.00214	0.0134	CcSEcCtD
Spironolactone—Erythema multiforme—Sorafenib—thyroid cancer	0.0021	0.0132	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00202	0.0126	CcSEcCtD
Spironolactone—Rash erythematous—Doxorubicin—thyroid cancer	0.00198	0.0124	CcSEcCtD
Spironolactone—Alopecia—Sorafenib—thyroid cancer	0.00197	0.0123	CcSEcCtD
Spironolactone—NR3C2—saliva-secreting gland—thyroid cancer	0.00196	0.0796	CbGeAlD
Spironolactone—Breast pain—Epirubicin—thyroid cancer	0.00188	0.0117	CcSEcCtD
Spironolactone—Amenorrhoea—Epirubicin—thyroid cancer	0.00186	0.0116	CcSEcCtD
Spironolactone—Muscle spasms—Sorafenib—thyroid cancer	0.00186	0.0116	CcSEcCtD
Spironolactone—Body temperature increased—Vandetanib—thyroid cancer	0.00185	0.0116	CcSEcCtD
Spironolactone—Breast pain—Doxorubicin—thyroid cancer	0.00174	0.0109	CcSEcCtD
Spironolactone—Leukopenia—Sorafenib—thyroid cancer	0.00173	0.0108	CcSEcCtD
Spironolactone—Ulcer—Epirubicin—thyroid cancer	0.00173	0.0108	CcSEcCtD
Spironolactone—Amenorrhoea—Doxorubicin—thyroid cancer	0.00172	0.0108	CcSEcCtD
Spironolactone—CYP11B2—lymph node—thyroid cancer	0.00169	0.0684	CbGeAlD
Spironolactone—Pruritus—Vandetanib—thyroid cancer	0.00166	0.0104	CcSEcCtD
Spironolactone—Hyperkalaemia—Epirubicin—thyroid cancer	0.00161	0.0101	CcSEcCtD
Spironolactone—Diarrhoea—Vandetanib—thyroid cancer	0.0016	0.01	CcSEcCtD
Spironolactone—Ulcer—Doxorubicin—thyroid cancer	0.0016	0.01	CcSEcCtD
Spironolactone—Anaphylactic shock—Sorafenib—thyroid cancer	0.00158	0.00988	CcSEcCtD
Spironolactone—Dizziness—Vandetanib—thyroid cancer	0.00155	0.00969	CcSEcCtD
Spironolactone—Thrombocytopenia—Sorafenib—thyroid cancer	0.00155	0.00968	CcSEcCtD
Spironolactone—NR3C2—trachea—thyroid cancer	0.00151	0.0614	CbGeAlD
Spironolactone—Cramps of lower extremities—Epirubicin—thyroid cancer	0.0015	0.0094	CcSEcCtD
Spironolactone—Vomiting—Vandetanib—thyroid cancer	0.00149	0.00931	CcSEcCtD
Spironolactone—Hyperkalaemia—Doxorubicin—thyroid cancer	0.00149	0.00931	CcSEcCtD
Spironolactone—Rash—Vandetanib—thyroid cancer	0.00148	0.00924	CcSEcCtD
Spironolactone—Dermatitis—Vandetanib—thyroid cancer	0.00148	0.00923	CcSEcCtD
Spironolactone—Headache—Vandetanib—thyroid cancer	0.00147	0.00918	CcSEcCtD
Spironolactone—Nausea—Vandetanib—thyroid cancer	0.00139	0.0087	CcSEcCtD
Spironolactone—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.00139	0.0087	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00136	0.00853	CcSEcCtD
Spironolactone—NR3C1—neck—thyroid cancer	0.00135	0.0548	CbGeAlD
Spironolactone—Renal failure acute—Epirubicin—thyroid cancer	0.00129	0.00805	CcSEcCtD
Spironolactone—Urticaria—Sorafenib—thyroid cancer	0.00126	0.00785	CcSEcCtD
Spironolactone—Body temperature increased—Sorafenib—thyroid cancer	0.00125	0.00781	CcSEcCtD
Spironolactone—SHBG—thyroid gland—thyroid cancer	0.00124	0.0501	CbGeAlD
Spironolactone—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.00123	0.00479	CbGpPWpGaD
Spironolactone—Lethargy—Epirubicin—thyroid cancer	0.00121	0.00758	CcSEcCtD
Spironolactone—NR3C2—thyroid gland—thyroid cancer	0.0012	0.0486	CbGeAlD
Spironolactone—PGR—Generic Transcription Pathway—TRIM33—thyroid cancer	0.0012	0.00467	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of Androgen receptor activity—RXRA—thyroid cancer	0.00119	0.00465	CbGpPWpGaD
Spironolactone—Renal failure acute—Doxorubicin—thyroid cancer	0.00119	0.00745	CcSEcCtD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00118	0.00462	CbGpPWpGaD
Spironolactone—Hypersensitivity—Sorafenib—thyroid cancer	0.00116	0.00728	CcSEcCtD
Spironolactone—NR3C1—Circadian Clock—RXRA—thyroid cancer	0.00116	0.00452	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00115	0.00448	CbGpPWpGaD
Spironolactone—Lethargy—Doxorubicin—thyroid cancer	0.00112	0.00702	CcSEcCtD
Spironolactone—Pruritus—Sorafenib—thyroid cancer	0.00112	0.00699	CcSEcCtD
Spironolactone—Ataxia—Epirubicin—thyroid cancer	0.00112	0.00699	CcSEcCtD
Spironolactone—PGR—thyroid gland—thyroid cancer	0.00111	0.0452	CbGeAlD
Spironolactone—Diarrhoea—Sorafenib—thyroid cancer	0.00108	0.00676	CcSEcCtD
Spironolactone—AR—Integrated Breast Cancer Pathway—TPR—thyroid cancer	0.00108	0.00422	CbGpPWpGaD
Spironolactone—CYP11B2—Biological oxidations—RXRA—thyroid cancer	0.00108	0.00421	CbGpPWpGaD
Spironolactone—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00107	0.00669	CcSEcCtD
Spironolactone—NR3C2—head—thyroid cancer	0.00106	0.0431	CbGeAlD
Spironolactone—NR3C1—saliva-secreting gland—thyroid cancer	0.00105	0.0427	CbGeAlD
Spironolactone—Gastritis—Epirubicin—thyroid cancer	0.00105	0.00658	CcSEcCtD
Spironolactone—Dizziness—Sorafenib—thyroid cancer	0.00104	0.00653	CcSEcCtD
Spironolactone—AR—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00104	0.00404	CbGpPWpGaD
Spironolactone—Ataxia—Doxorubicin—thyroid cancer	0.00103	0.00646	CcSEcCtD
Spironolactone—NR3C1—AP-1 transcription factor network—CDK1—thyroid cancer	0.00103	0.00401	CbGpPWpGaD
Spironolactone—AR—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00102	0.00399	CbGpPWpGaD
Spironolactone—Eosinophilia—Epirubicin—thyroid cancer	0.00102	0.00636	CcSEcCtD
Spironolactone—Vomiting—Sorafenib—thyroid cancer	0.001	0.00628	CcSEcCtD
Spironolactone—Rash—Sorafenib—thyroid cancer	0.000996	0.00623	CcSEcCtD
Spironolactone—Dermatitis—Sorafenib—thyroid cancer	0.000995	0.00622	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00099	0.00619	CcSEcCtD
Spironolactone—Headache—Sorafenib—thyroid cancer	0.00099	0.00619	CcSEcCtD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000988	0.00386	CbGpPWpGaD
Spironolactone—PGR—head—thyroid cancer	0.000988	0.0401	CbGeAlD
Spironolactone—NR3C1—Nuclear Receptors—PPARG—thyroid cancer	0.000982	0.00383	CbGpPWpGaD
Spironolactone—Gastritis—Doxorubicin—thyroid cancer	0.000973	0.00608	CcSEcCtD
Spironolactone—CYP2C8—Metapathway biotransformation—CHST14—thyroid cancer	0.00097	0.00379	CbGpPWpGaD
Spironolactone—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000958	0.00374	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—CDK1—thyroid cancer	0.000956	0.00373	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—TRIM33—thyroid cancer	0.000945	0.00369	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—BRAF—thyroid cancer	0.000943	0.00368	CbGpPWpGaD
Spironolactone—Eosinophilia—Doxorubicin—thyroid cancer	0.000941	0.00588	CcSEcCtD
Spironolactone—Nausea—Sorafenib—thyroid cancer	0.000938	0.00587	CcSEcCtD
Spironolactone—CYP11B1—Biological oxidations—RXRA—thyroid cancer	0.00093	0.00363	CbGpPWpGaD
Spironolactone—Drowsiness—Epirubicin—thyroid cancer	0.000915	0.00573	CcSEcCtD
Spironolactone—SLCO1A2—head—thyroid cancer	0.000911	0.037	CbGeAlD
Spironolactone—AR—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000911	0.00356	CbGpPWpGaD
Spironolactone—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000908	0.00568	CcSEcCtD
Spironolactone—NR3C2—Generic Transcription Pathway—MEN1—thyroid cancer	0.000901	0.00352	CbGpPWpGaD
Spironolactone—Renal failure—Epirubicin—thyroid cancer	0.0009	0.00563	CcSEcCtD
Spironolactone—AR—thyroid gland—thyroid cancer	0.000887	0.036	CbGeAlD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—thyroid cancer	0.000877	0.00342	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—THRB—thyroid cancer	0.000864	0.00337	CbGpPWpGaD
Spironolactone—NR3C1—Circadian Clock—HIF1A—thyroid cancer	0.000859	0.00335	CbGpPWpGaD
Spironolactone—Agranulocytosis—Epirubicin—thyroid cancer	0.000854	0.00534	CcSEcCtD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000854	0.00333	CbGpPWpGaD
Spironolactone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.00085	0.00332	CbGpPWpGaD
Spironolactone—Drowsiness—Doxorubicin—thyroid cancer	0.000847	0.0053	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00084	0.00525	CcSEcCtD
Spironolactone—Renal failure—Doxorubicin—thyroid cancer	0.000833	0.00521	CcSEcCtD
Spironolactone—AR—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000819	0.0032	CbGpPWpGaD
Spironolactone—NR3C1—trachea—thyroid cancer	0.000812	0.0329	CbGeAlD
Spironolactone—PGR—Validated nuclear estrogen receptor alpha network—CCND1—thyroid cancer	0.000796	0.00311	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—MINPP1—thyroid cancer	0.000793	0.00309	CbGpPWpGaD
Spironolactone—Agranulocytosis—Doxorubicin—thyroid cancer	0.00079	0.00494	CcSEcCtD
Spironolactone—AR—head—thyroid cancer	0.000787	0.0319	CbGeAlD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.000786	0.00307	CbGpPWpGaD
Spironolactone—Erythema multiforme—Epirubicin—thyroid cancer	0.000777	0.00486	CcSEcCtD
Spironolactone—NR3C1—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000776	0.00303	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—NRG1—thyroid cancer	0.000767	0.003	CbGpPWpGaD
Spironolactone—NR3C2—lymph node—thyroid cancer	0.000744	0.0302	CbGeAlD
Spironolactone—Alopecia—Epirubicin—thyroid cancer	0.000726	0.00454	CcSEcCtD
Spironolactone—ABCC2—NRF2 pathway—SLC5A5—thyroid cancer	0.00072	0.00281	CbGpPWpGaD
Spironolactone—Erythema multiforme—Doxorubicin—thyroid cancer	0.000719	0.0045	CcSEcCtD
Spironolactone—NR3C1—AP-1 transcription factor network—HIF1A—thyroid cancer	0.000708	0.00276	CbGpPWpGaD
Spironolactone—PGR—lymph node—thyroid cancer	0.000692	0.0281	CbGeAlD
Spironolactone—NR3C1—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000691	0.0027	CbGpPWpGaD
Spironolactone—Muscle spasms—Epirubicin—thyroid cancer	0.000688	0.0043	CcSEcCtD
Spironolactone—NR3C2—Gene Expression—THRB—thyroid cancer	0.000683	0.00267	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—MINPP1—thyroid cancer	0.000683	0.00267	CbGpPWpGaD
Spironolactone—AR—Nongenotropic Androgen signaling—HRAS—thyroid cancer	0.000682	0.00266	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—NDUFA13—thyroid cancer	0.000674	0.00263	CbGpPWpGaD
Spironolactone—Alopecia—Doxorubicin—thyroid cancer	0.000672	0.0042	CcSEcCtD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.00067	0.00262	CbGpPWpGaD
Spironolactone—SLCO1A2—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000666	0.0026	CbGpPWpGaD
Spironolactone—SLCO1A2—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000666	0.0026	CbGpPWpGaD
Spironolactone—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000665	0.0026	CbGpPWpGaD
Spironolactone—Ill-defined disorder—Epirubicin—thyroid cancer	0.000664	0.00415	CcSEcCtD
Spironolactone—AR—Generic Transcription Pathway—THRB—thyroid cancer	0.000658	0.00257	CbGpPWpGaD
Spironolactone—Malaise—Epirubicin—thyroid cancer	0.000645	0.00404	CcSEcCtD
Spironolactone—NR3C1—thyroid gland—thyroid cancer	0.000642	0.0261	CbGeAlD
Spironolactone—Leukopenia—Epirubicin—thyroid cancer	0.00064	0.00401	CcSEcCtD
Spironolactone—Muscle spasms—Doxorubicin—thyroid cancer	0.000636	0.00398	CcSEcCtD
Spironolactone—CYP11B2—Metabolism—CHST14—thyroid cancer	0.000634	0.00247	CbGpPWpGaD
Spironolactone—AR—Coregulation of Androgen receptor activity—CCND1—thyroid cancer	0.00063	0.00246	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000621	0.00242	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00062	0.00242	CbGpPWpGaD
Spironolactone—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000614	0.00384	CcSEcCtD
Spironolactone—ABCC2—NRF2 pathway—RXRA—thyroid cancer	0.000605	0.00236	CbGpPWpGaD
Spironolactone—NR3C2—Generic Transcription Pathway—RXRA—thyroid cancer	0.000603	0.00235	CbGpPWpGaD
Spironolactone—AR—Nongenotropic Androgen signaling—AKT1—thyroid cancer	0.000602	0.00235	CbGpPWpGaD
Spironolactone—Discomfort—Epirubicin—thyroid cancer	0.000602	0.00376	CcSEcCtD
Spironolactone—Malaise—Doxorubicin—thyroid cancer	0.000597	0.00373	CcSEcCtD
Spironolactone—ABCC2—lymph node—thyroid cancer	0.000594	0.0241	CbGeAlD
Spironolactone—Leukopenia—Doxorubicin—thyroid cancer	0.000593	0.00371	CcSEcCtD
Spironolactone—Confusional state—Epirubicin—thyroid cancer	0.000589	0.00368	CcSEcCtD
Spironolactone—Anaphylactic shock—Epirubicin—thyroid cancer	0.000584	0.00365	CcSEcCtD
Spironolactone—NR3C1—Adipogenesis—RXRA—thyroid cancer	0.000581	0.00227	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—NDUFA13—thyroid cancer	0.000581	0.00227	CbGpPWpGaD
Spironolactone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000576	0.00225	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—TRIM33—thyroid cancer	0.000576	0.00225	CbGpPWpGaD
Spironolactone—Thrombocytopenia—Epirubicin—thyroid cancer	0.000572	0.00358	CcSEcCtD
Spironolactone—NR3C1—head—thyroid cancer	0.00057	0.0231	CbGeAlD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000563	0.0022	CbGpPWpGaD
Spironolactone—Discomfort—Doxorubicin—thyroid cancer	0.000557	0.00348	CcSEcCtD
Spironolactone—AR—lymph node—thyroid cancer	0.000551	0.0224	CbGeAlD
Spironolactone—PGR—Generic Transcription Pathway—MEN1—thyroid cancer	0.000549	0.00214	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—CHST14—thyroid cancer	0.000546	0.00213	CbGpPWpGaD
Spironolactone—Confusional state—Doxorubicin—thyroid cancer	0.000545	0.00341	CcSEcCtD
Spironolactone—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00054	0.00338	CcSEcCtD
Spironolactone—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000539	0.00211	CbGpPWpGaD
Spironolactone—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000529	0.00331	CcSEcCtD
Spironolactone—ABCC2—NRF2 pathway—NRG1—thyroid cancer	0.000523	0.00204	CbGpPWpGaD
Spironolactone—Somnolence—Epirubicin—thyroid cancer	0.000519	0.00325	CcSEcCtD
Spironolactone—CYP11B2—Metabolism—HPGD—thyroid cancer	0.000511	0.00199	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—thyroid cancer	0.000507	0.00198	CbGpPWpGaD
Spironolactone—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000504	0.00315	CcSEcCtD
Spironolactone—NR3C1—Generic Transcription Pathway—THRB—thyroid cancer	0.0005	0.00195	CbGpPWpGaD
Spironolactone—SLCO1A2—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000499	0.00195	CbGpPWpGaD
Spironolactone—AR—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000492	0.00192	CbGpPWpGaD
Spironolactone—Feeling abnormal—Epirubicin—thyroid cancer	0.000481	0.00301	CcSEcCtD
Spironolactone—Somnolence—Doxorubicin—thyroid cancer	0.00048	0.003	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000466	0.00292	CcSEcCtD
Spironolactone—AR—Androgen receptor signaling pathway—CCND1—thyroid cancer	0.000466	0.00182	CbGpPWpGaD
Spironolactone—Urticaria—Epirubicin—thyroid cancer	0.000464	0.0029	CcSEcCtD
Spironolactone—Body temperature increased—Epirubicin—thyroid cancer	0.000462	0.00289	CcSEcCtD
Spironolactone—NR3C2—Gene Expression—TPR—thyroid cancer	0.000461	0.0018	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—PTEN—thyroid cancer	0.000449	0.00175	CbGpPWpGaD
Spironolactone—Feeling abnormal—Doxorubicin—thyroid cancer	0.000445	0.00278	CcSEcCtD
Spironolactone—CYP11B1—Metabolism—HPGD—thyroid cancer	0.00044	0.00172	CbGpPWpGaD
Spironolactone—AR—Gene Expression—TRIM33—thyroid cancer	0.000438	0.00171	CbGpPWpGaD
Spironolactone—ABCB1—trachea—thyroid cancer	0.000435	0.0176	CbGeAlD
Spironolactone—NR3C2—Gene Expression—MEN1—thyroid cancer	0.000434	0.00169	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—HIF1A—thyroid cancer	0.000432	0.00168	CbGpPWpGaD
Spironolactone—Hypersensitivity—Epirubicin—thyroid cancer	0.00043	0.00269	CcSEcCtD
Spironolactone—Urticaria—Doxorubicin—thyroid cancer	0.000429	0.00268	CcSEcCtD
Spironolactone—SLCO1A2—Metabolism—MINPP1—thyroid cancer	0.000428	0.00167	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—CCND1—thyroid cancer	0.000428	0.00167	CbGpPWpGaD
Spironolactone—Body temperature increased—Doxorubicin—thyroid cancer	0.000427	0.00267	CcSEcCtD
Spironolactone—AR—Generic Transcription Pathway—MEN1—thyroid cancer	0.000418	0.00163	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.000418	0.00163	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000417	0.00163	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—THRB—thyroid cancer	0.000416	0.00162	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000414	0.00162	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—PTEN—thyroid cancer	0.000413	0.00161	CbGpPWpGaD
Spironolactone—Pruritus—Epirubicin—thyroid cancer	0.000413	0.00258	CcSEcCtD
Spironolactone—Diarrhoea—Epirubicin—thyroid cancer	0.000399	0.0025	CcSEcCtD
Spironolactone—NR3C1—lymph node—thyroid cancer	0.000399	0.0162	CbGeAlD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000399	0.00156	CbGpPWpGaD
Spironolactone—Hypersensitivity—Doxorubicin—thyroid cancer	0.000398	0.00249	CcSEcCtD
Spironolactone—PGR—Signaling Pathways—CALCB—thyroid cancer	0.000395	0.00154	CbGpPWpGaD
Spironolactone—Dizziness—Epirubicin—thyroid cancer	0.000386	0.00241	CcSEcCtD
Spironolactone—PGR—Signaling by ERBB4—PTEN—thyroid cancer	0.000384	0.0015	CbGpPWpGaD
Spironolactone—CYP11B1—Corticotropin-releasing hormone—AKT1—thyroid cancer	0.000383	0.00149	CbGpPWpGaD
Spironolactone—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000382	0.00149	CbGpPWpGaD
Spironolactone—Pruritus—Doxorubicin—thyroid cancer	0.000382	0.00239	CcSEcCtD
Spironolactone—NR3C2—Generic Transcription Pathway—PPARG—thyroid cancer	0.000381	0.00149	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TRIM33—thyroid cancer	0.000374	0.00146	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000373	0.00146	CbGpPWpGaD
Spironolactone—Vomiting—Epirubicin—thyroid cancer	0.000371	0.00232	CcSEcCtD
Spironolactone—Diarrhoea—Doxorubicin—thyroid cancer	0.00037	0.00231	CcSEcCtD
Spironolactone—Rash—Epirubicin—thyroid cancer	0.000368	0.0023	CcSEcCtD
Spironolactone—Dermatitis—Epirubicin—thyroid cancer	0.000368	0.0023	CcSEcCtD
Spironolactone—PGR—Generic Transcription Pathway—RXRA—thyroid cancer	0.000367	0.00143	CbGpPWpGaD
Spironolactone—NR3C1—Adipogenesis—PPARG—thyroid cancer	0.000367	0.00143	CbGpPWpGaD
Spironolactone—Headache—Epirubicin—thyroid cancer	0.000366	0.00229	CcSEcCtD
Spironolactone—SLCO1A2—Metabolism—NDUFA13—thyroid cancer	0.000364	0.00142	CbGpPWpGaD
Spironolactone—Dizziness—Doxorubicin—thyroid cancer	0.000357	0.00223	CcSEcCtD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000357	0.00139	CbGpPWpGaD
Spironolactone—AR—Coregulation of Androgen receptor activity—AKT1—thyroid cancer	0.00035	0.00137	CbGpPWpGaD
Spironolactone—Nausea—Epirubicin—thyroid cancer	0.000347	0.00217	CcSEcCtD
Spironolactone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.000345	0.00135	CbGpPWpGaD
Spironolactone—ABCB1—thyroid gland—thyroid cancer	0.000344	0.014	CbGeAlD
Spironolactone—Vomiting—Doxorubicin—thyroid cancer	0.000343	0.00215	CcSEcCtD
Spironolactone—PGR—Signaling by ERBB4—NRAS—thyroid cancer	0.000343	0.00134	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CHST14—thyroid cancer	0.000342	0.00134	CbGpPWpGaD
Spironolactone—Rash—Doxorubicin—thyroid cancer	0.000341	0.00213	CcSEcCtD
Spironolactone—Dermatitis—Doxorubicin—thyroid cancer	0.00034	0.00213	CcSEcCtD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000338	0.00132	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000338	0.00132	CbGpPWpGaD
Spironolactone—Headache—Doxorubicin—thyroid cancer	0.000338	0.00212	CcSEcCtD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000333	0.0013	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—TRIM33—thyroid cancer	0.000333	0.0013	CbGpPWpGaD
Spironolactone—Nausea—Doxorubicin—thyroid cancer	0.000321	0.00201	CcSEcCtD
Spironolactone—NR3C1—Generic Transcription Pathway—MEN1—thyroid cancer	0.000317	0.00124	CbGpPWpGaD
Spironolactone—AR—Gene Expression—THRB—thyroid cancer	0.000317	0.00124	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000308	0.0012	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000308	0.0012	CbGpPWpGaD
Spironolactone—ABCB1—head—thyroid cancer	0.000305	0.0124	CbGeAlD
Spironolactone—AR—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.000305	0.00119	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000305	0.00119	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000303	0.00118	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—KRAS—thyroid cancer	0.000295	0.00115	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.000294	0.00115	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—TPR—thyroid cancer	0.000293	0.00115	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—RXRA—thyroid cancer	0.00029	0.00113	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PRKAR1A—thyroid cancer	0.000289	0.00113	CbGpPWpGaD
Spironolactone—CYP2C8—Biological oxidations—RXRA—thyroid cancer	0.000286	0.00112	CbGpPWpGaD
Spironolactone—NR3C1—AP-1 transcription factor network—TP53—thyroid cancer	0.000282	0.0011	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—TPR—thyroid cancer	0.000281	0.0011	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—RXRA—thyroid cancer	0.00028	0.00109	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.00028	0.00109	CbGpPWpGaD
Spironolactone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.000279	0.00109	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—HPGD—thyroid cancer	0.000276	0.00108	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MEN1—thyroid cancer	0.000264	0.00103	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000262	0.00102	CbGpPWpGaD
Spironolactone—AR—Androgen receptor signaling pathway—AKT1—thyroid cancer	0.000259	0.00101	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000253	0.000989	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—TPR—thyroid cancer	0.000253	0.000987	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000253	0.000987	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—HRAS—thyroid cancer	0.000251	0.000979	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TCF7L1—thyroid cancer	0.00025	0.000975	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PRKAR1A—thyroid cancer	0.000249	0.000971	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—TP53—thyroid cancer	0.000248	0.00097	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000244	0.000952	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—THRB—thyroid cancer	0.000241	0.000939	CbGpPWpGaD
Spironolactone—PGR—Generic Transcription Pathway—PPARG—thyroid cancer	0.000232	0.000905	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000231	0.000901	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.00023	0.000896	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.000226	0.000882	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000225	0.00088	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000224	0.000874	CbGpPWpGaD
Spironolactone—PGR—Signaling by ERBB4—AKT1—thyroid cancer	0.000222	0.000865	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—SLC5A5—thyroid cancer	0.00022	0.000857	CbGpPWpGaD
Spironolactone—AR—Gene Expression—TPR—thyroid cancer	0.000214	0.000836	CbGpPWpGaD
Spironolactone—ABCB1—lymph node—thyroid cancer	0.000214	0.00867	CbGeAlD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000213	0.000831	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—RXRA—thyroid cancer	0.000212	0.000828	CbGpPWpGaD
Spironolactone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.000212	0.000827	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MINPP1—thyroid cancer	0.00021	0.000822	CbGpPWpGaD
Spironolactone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—thyroid cancer	0.00021	0.000819	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000206	0.000803	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MEN1—thyroid cancer	0.000201	0.000786	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.000201	0.000784	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000194	0.000757	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—SLC5A5—thyroid cancer	0.000189	0.000739	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000187	0.000731	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—RXRA—thyroid cancer	0.000185	0.00072	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MINPP1—thyroid cancer	0.000183	0.000716	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—PPARG—thyroid cancer	0.000183	0.000715	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TSHR—thyroid cancer	0.000183	0.000713	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PRKAR1A—thyroid cancer	0.00018	0.000702	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000179	0.000701	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—NDUFA13—thyroid cancer	0.000179	0.000699	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000177	0.000692	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—RXRA—thyroid cancer	0.000177	0.00069	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—PPARG—thyroid cancer	0.000177	0.000689	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MEN1—thyroid cancer	0.000172	0.000671	CbGpPWpGaD
Spironolactone—AR—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	0.00017	0.000662	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CHST14—thyroid cancer	0.000168	0.000657	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000166	0.00065	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—TPR—thyroid cancer	0.000162	0.000634	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—RXRA—thyroid cancer	0.000159	0.000621	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—TPR—thyroid cancer	0.000159	0.000619	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PRKAR1A—thyroid cancer	0.000156	0.000609	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—NDUFA13—thyroid cancer	0.000156	0.000609	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTCH1—thyroid cancer	0.000155	0.000607	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000155	0.000604	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MEN1—thyroid cancer	0.000153	0.000596	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CHST14—thyroid cancer	0.000147	0.000572	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000145	0.000566	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000145	0.000566	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000143	0.000556	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SST—thyroid cancer	0.000142	0.000555	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000141	0.000552	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000141	0.000549	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CALCA—thyroid cancer	0.000137	0.000534	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HPGD—thyroid cancer	0.000136	0.000529	CbGpPWpGaD
Spironolactone—AR—Gene Expression—RXRA—thyroid cancer	0.000135	0.000526	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	0.000134	0.000523	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—PPARG—thyroid cancer	0.000134	0.000523	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDK1—thyroid cancer	0.000124	0.000483	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—SLC5A5—thyroid cancer	0.000119	0.000463	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HPGD—thyroid cancer	0.000118	0.000461	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PPARG—thyroid cancer	0.000117	0.000455	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000114	0.000445	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—PPARG—thyroid cancer	0.000112	0.000436	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000111	0.000434	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.00011	0.000429	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000108	0.000423	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000103	0.000402	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—RXRA—thyroid cancer	0.000102	0.000399	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PPARG—thyroid cancer	0.0001	0.000392	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—RXRA—thyroid cancer	9.97e-05	0.000389	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	9.94e-05	0.000388	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NRG1—thyroid cancer	9.94e-05	0.000388	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	9.7e-05	0.000379	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTGS2—thyroid cancer	9.17e-05	0.000358	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	9.11e-05	0.000356	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TERT—thyroid cancer	8.92e-05	0.000348	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HIF1A—thyroid cancer	8.53e-05	0.000333	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PPARG—thyroid cancer	8.5e-05	0.000332	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTEN—thyroid cancer	7.99e-05	0.000312	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS2—thyroid cancer	7.9e-05	0.000308	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—TPR—thyroid cancer	7.79e-05	0.000304	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	7.66e-05	0.000299	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	7.63e-05	0.000298	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—AKT1—thyroid cancer	7.25e-05	0.000283	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—BRAF—thyroid cancer	7.07e-05	0.000276	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	6.95e-05	0.000271	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTEN—thyroid cancer	6.89e-05	0.000269	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—TPR—thyroid cancer	6.79e-05	0.000265	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	6.79e-05	0.000265	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PRKAR1A—thyroid cancer	6.68e-05	0.000261	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PPARG—thyroid cancer	6.45e-05	0.000252	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PPARG—thyroid cancer	6.3e-05	0.000246	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC5A5—thyroid cancer	5.83e-05	0.000228	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	5.73e-05	0.000224	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.46e-05	0.000213	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCND1—thyroid cancer	5.16e-05	0.000201	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC5A5—thyroid cancer	5.08e-05	0.000198	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTEN—thyroid cancer	4.98e-05	0.000194	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTGS2—thyroid cancer	4.95e-05	0.000193	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—RXRA—thyroid cancer	4.9e-05	0.000191	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.77e-05	0.000186	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—AKT1—thyroid cancer	4.61e-05	0.00018	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NRAS—thyroid cancer	4.44e-05	0.000173	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—AKT1—thyroid cancer	4.41e-05	0.000172	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTEN—thyroid cancer	4.32e-05	0.000169	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—RXRA—thyroid cancer	4.27e-05	0.000167	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AKT1—thyroid cancer	3.97e-05	0.000155	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KRAS—thyroid cancer	3.82e-05	0.000149	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—thyroid cancer	3.4e-05	0.000133	CbGpPWpGaD
Spironolactone—AR—Gene Expression—AKT1—thyroid cancer	3.36e-05	0.000131	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HRAS—thyroid cancer	3.25e-05	0.000127	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPARG—thyroid cancer	3.09e-05	0.000121	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKT1—thyroid cancer	2.87e-05	0.000112	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPARG—thyroid cancer	2.7e-05	0.000105	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—AKT1—thyroid cancer	2.55e-05	9.96e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AKT1—thyroid cancer	2.49e-05	9.72e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS2—thyroid cancer	2.43e-05	9.5e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTEN—thyroid cancer	2.12e-05	8.28e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS2—thyroid cancer	2.12e-05	8.28e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTEN—thyroid cancer	1.85e-05	7.22e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKT1—thyroid cancer	1.22e-05	4.77e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKT1—thyroid cancer	1.07e-05	4.16e-05	CbGpPWpGaD
